newsfilter
← Latest News
GlobeNewswire·

ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director

SAN CARLOS, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ:CCXI), today announced that Jennifer L. Herron has been appointed to the Board as an independent director, effective June 28, 2022. With this appointment, the Board incre